National plan for neurological conditions could save Australia $7 billion a year

MS Australia CEO and Chair of the Neurological Alliance Australia Rohan Greenland presents the Blueprint to Assistant Health Minister the Hon Rebecca White MP

National plan for neurological conditions could save Australia $7 billion a year

MS Australia CEO and Chair of the Neurological Alliance Australia Rohan Greenland presents the Blueprint to Assistant Health Minister the Hon Rebecca White MP

MS Research Incubator Grants Announcement

Four new projects address MS Australia’s priorities for MS research, including causes and prevention, better treatments and cures via repair and regeneration of cells.

MS Research Incubator Grants Announcement

Four new projects address MS Australia’s priorities for MS research, including causes and prevention, better treatments and cures via repair and regeneration of cells.

Together with the broader sector, we are concerned by the decision relating to pricing for therapy supports, support coordination and plan management.

The price is not right! NDIS pricing failure hurts sector and the disability community

Together with the broader sector, we are concerned by the decision relating to pricing for therapy supports, support coordination and plan management.

Living well with MS

MS Australia’s new wellness resources offer clear, evidence-informed guidance to support lifestyle decisions related to MS.

Living well with MS

MS Australia’s new wellness resources offer clear, evidence-informed guidance to support lifestyle decisions related to MS.

Global multiple sclerosis prevention initiative underway

MS Canada and MS Australia lead new global initiative into the prevention and ultra-early detection of MS

Global multiple sclerosis prevention initiative underway

MS Canada and MS Australia lead new global initiative into the prevention and ultra-early detection of MS

3-5 December 2025
Sofitel Brisbane Central

MS Australia Research Conference 2025

3-5 December 2025
Sofitel Brisbane Central

EBV in MS

The goal of the EBV in MS Platform is to better understand the role of EBV in the development of MS and in ongoing disease; and the potential to target EBV to prevent or treat MS

EBV in MS

The goal of the EBV in MS Platform is to better understand the role of EBV in the development of MS and in ongoing disease; and the potential to target EBV to prevent or treat MS

“PLATYPUS” - PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis - multi-arm, multi-stage (MAMS) clinical trial which will test two repurposed drugs to help people living with progressive MS. 

PLATYPUS

“PLATYPUS” - PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis - multi-arm, multi-stage (MAMS) clinical trial which will test two repurposed drugs to help people living with progressive MS. 

Join us for news and views on the latest research, treatments, and advocacy efforts, as well as candid and informative interviews with our community; those living with MS and their families and carers, together with leading clinicians, researchers, and advocates.

The Raw Nerve Podcast

Join us for news and views on the latest research, treatments, and advocacy efforts, as well as candid and informative interviews with our community; those living with MS and their families and carers, together with leading clinicians, researchers, and advocates.

Our mission: a world without MS

MS News

25 September 2025

CEO Rohan Greenland shares five areas of special interest he’s watching closely as the world’s largest MS research congress, ECTRIMS,…
MS News

25 September 2025

The International Progressive MS Alliance has collated MRI and clinical data from over 13,000 people to answer big questions in…
MS News

25 September 2025

In this Q&A, Associate Professor Litza Kiropoulos discusses the connection between MS and mental health and her MS Australia-supported research…
MS News

23 September 2025

We are deeply saddened to learn that MS South Australia & Northern Territory (MS SA&NT) has entered into voluntary administration….

22 September 2025

Marking the Neurological Alliance Australia’s September 2025 inspirational Day of Action and presentation to government of a Blueprint designed to…
MS News

18 September 2025

The McDonald Diagnostic Criteria for MS have been updated to help people get diagnosed faster and more accurately….
Media Release

18 September 2025

Updated international guidelines for diagnosing multiple sclerosis (MS) were published today, enabling earlier and more accurate diagnosis so people can…
MS News

2 September 2025

Reporting side effects, even minor ones, is one way people with MS can contribute to safer treatment for everyone….

1 September 2025

Join us for a special episode on women’s health and MS, hosted by Dr Tennille Luker, MS Australia’s Head of…
MS News

27 August 2025

CEO Rohan Greenland details the upcoming handover of the Blueprint for a National Action Plan for Neurological Conditions, a prod…
Read More

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Home